The ROE as of December 2025 (TTM) for Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) is -23.27%

According to Guangzhou Innogen Pharmaceutl Grp Co Ltd’s latest financial reports and current stock price. The company's current ROE is -23.27%. This represents a change of -Infinity% compared to the average of 0% of the last 4 quarters.

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) Historical ROE (quarterly & annually)

How has 2591.HK ROE performed in the past?

The mean historical ROE of Guangzhou Innogen Pharmaceutl Grp Co Ltd over the last ten years is -62.97%. The current -23.27% ROE has changed -63.05% with respect to the historical average. Over the past ten years (40 quarters), 2591.HK's ROE was at its highest in in the May 2025 quarter at 0%. The ROE was at its lowest in in the May 2025 quarter at 0%.

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Guangzhou Innogen Pharmaceutl Grp Co Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) Average ROE

How has 2591.HK ROE performed in the past?

The current ROE of Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) ROE vs. Peers

How is 2591.HK’s ROE compared to its peers?

Guangzhou Innogen Pharmaceutl Grp Co Ltd’s ROE is greater than Lepu Biopharma Co., Ltd. (-24.47%), less than Nanjing Leads Biolabs Co Ltd (0%), less than Shanghai Haohai Biological Technology Co., Ltd. (6.84%), greater than Everest Medicines Limited (-16.47%), less than Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (15.32%), greater than Keymed Biosciences Inc. (-9.08%), less than Alphamab Oncology (12.63%), greater than Sihuan Pharmaceutical Holdings Group Ltd. (-1.84%), less than HBM Holdings Limited (18.28%), greater than Ab&B Bio Tech Co Ltd. (-101.49%),

Build a custom stock screener for Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guangzhou Innogen Pharmaceutl Grp Co Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Guangzhou Innogen Pharmaceutl Grp Co Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.